Drug companies and neuroprotection of the newborn: any hope for a love story?
Gressens
Pierre
P
Inserm, U676, Université Paris 7, Faculté de Médecine Denis Diderot, IFR02 and IFR25, Ap HP, Hôpital Robert Debré, Service de Neurologie Pédiatrique; Paris, France. gressens@rdebre.inserm.fr
D035843:Biomedical Research / Q000458:organization & administration*; D001925:Brain Damage, Chronic / Q000517:prevention & control*; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007231:Infant, Newborn; D018696:Neuroprotective Agents / Q000627:therapeutic use*
D018696:Neuroprotective Agents